Clene (NASDAQ:CLNN) reported quarterly losses of $(0.88) per share which missed the analyst consensus estimate of $(0.56) by 57.99 percent. This is a 47.31 percent increase over losses of $(1.67) per share from the same period last year. The company reported quarterly sales of $77.000 thousand which beat the analyst consensus estimate of $49.000 thousand by 57.14 percent. This is a 15.38 percent decrease over sales of $91.000 thousand the same period last year.